Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 160 participants.
Also called NCT04696523
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 160 participants
- Sponsor
- Registry
-
NCT04696523 -
2019-001542-17
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Finland, Sweden
- Registry status
- Recruiting
Technical summary
Registry record NCT04696523. Randomized; double masking; primary purpose treatment. Start 2025-04-22 (actual); primary completion 2029-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
- Acronym
- Xe-SAH
- Condition
- Subarachnoid Hemorrhage, Aneurysmal
- Condition
- Cerebral Injury
- Condition
- Cerebral Ischemia
- Condition
- Cerebral Infarction
- Condition
- Cardiac Event
- Condition
- Cardiac Failure
- Intervention (Drug)
- Xenon
- Intervention (Drug)
- air/oxygen
- Lead sponsor
- Turku University Hospital
- Collaborator
- Academy of Finland
Record details
- Record id
cardio:ct-nct04696523- Content hash
334a76f1345c447620cb2de78cfc81d82cfee5ae1665b1fac1d2028b9ecc0963